Indivior Plc Adr Stock News

Indivior PLC (OTCPK:INVVY) Q3 2023 Earnings Conference Call November 9, 2023 8:00 AM ET Company Participants Mark Crossley - CEO Ryan Preblick - CFO Dr. Christian Heidbreder - Chief Scientific Officer

Indivior CEO Mark Crossley joins 'Squawk Box' to discuss the company's mission, demand for substance abuse treatment, the opioid epidemic, and more.

Indivior Plc said on Friday its unit had agreed to pay $102.5 million to settle a lawsuit by multiple state attorneys general accusing it of using illegal tactics to shield its opioid addiction treatm

Indivior PLC (OTCPK:INVVY) Q1 2023 Earnings Conference Call April 27, 2023 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Mark Crossley - Chief Executive Officer

SLOUGH, UK and RICHMOND, Va. , April 25, 2023 /PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event: Bank of America Global Healthcare Confe

Indivior PLC (LSE:INDV)'s solid fundamentals have been overshadowed by market concerns about a $290m legal provision, according to Jefferies. Despite the company's recent litigation troubles, Jefferie

Indivior PLC (OTCPK:INVVY) Q4 2022 Earnings Conference Call February 16, 2023 8:00 AM ET Company Participants Jason Thompson - Vice President of Investor Relations Mark Crossley - Chief Executive Offi

Drug company Indivior PLC (LSE:INDV)'s shares plummeted 13% after it set aside US$290mln for ongoing litigation in the states. It covers “multidistrict antitrust class and state claims” and follow

Drug addiction is on the rise but so are treatments for it, like those provided by Indivior for opioid usage. With growing revenues and exceptional margins, its price is rising. Its price is already u

Indivior PLC (LSE:INDV) shares have been given a price target of 2,655p by Jefferies, implying over 40% upside, after the company raised sales guidance for its Sublocade slow-release treatment for opi

Indivior PLC (OTCPK:INVVY) Q3 2022 Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Mark Crossley - CEO Ryan Preblick - CFO Conference Call Participants Thibault Boutherin - M

If you are looking for stocks that are well positioned to maintain their recent uptrend, Indivior PLC (INVVY) could be a great choice. It is one of the several stocks that passed through our "Recent P

Indivior PLC (OTCPK:INVVY) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Christian Heid

Indivior PLC (INVVY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Indivior PLC (OTCPK:INVVY) Q1 2022 Results Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Mark Crossley - Chief Executive Officer Ryan Preblick - Chief Financial Officer Chris